Horizon 2020 EIC
The project has received funding from the European Union’s Horizon Europe Innovation Council under grant agreement 190134274 and from the Horizon 2020 research and innovation programme under grant agreement No. 874316.
For more information on Grant mechanism and the EIC
refer to project portal
Click Here
Description
Paragate’s Implantable Fluid Removal Device, is an active implant that acts as a mechanical bypass of the kidneys. The device is implanted in minimally invasive fashion and continuously (24/7) and gently absorbs systemic isotonic extracellular fluid and drains it to the urinary system. The system provides a home-based solution for continual prevention of fluid overload, to minimize need for repeated acute hospital admissions and enabling patient tailored and configurable therapy.
The objectives
The objectives of the project are to advance development of the system, perform needed verification and validation and conduct clinical testing. The Horizon Europe EIC program and our highly rated European partners within support us in further deliver the system to its ultimate goal, to bring better care for millions of patients across Europe and worldwide.
Please contact us for enquiries on project structure and current partners or open calls for research collaborations and consortium creation
